LEP and type 2 diabetes mellitus: Leptin treatment improves insulin resistance and hyperglycemia in a specific mouse model of type 2 diabetes MKR (transgenic overexpression of a skeletal muscle dominant-negative IGF-I receptor with a lysine-to-arginine amino acid).